Equity Research, Broker Reports, and media content on AstraZeneca

  • Access the latest forecasts, broker valuations, multiples, and video content from the city about AstraZeneca
  • See live updates from analysts, company announcements, and other news in a personalised/single dashboard

Research, Charts & Company Announcements

Research Tree provides access to ongoing research coverage, media content and regulatory news on AstraZeneca. We currently have 111 research reports from 9 professional analysts.

Open
7316p
Range Today
7256/7339p
52 Week
5325/7580p
Daily Volume
198.1k
# Shares
1,312m
Daily Liquidity
(0.02%)
Pension Liability
£2,842m
Enterprise Value
£110,417m
Market Cap
£95,888m
Latest PE (hist)
16.66
Div Yield
3.82
Date Source Announcement
12Dec19 07:00 RNS Imfinzi approved in China for Stage III NSCLC
11Dec19 13:00 RNS Trastuzumab deruxtecan achieves ORR of 60.9%
05Dec19 07:00 RNS Lynparza approved in China for 1L BRCAm ovarian
03Dec19 07:00 RNS AstraZeneca divests Seroquel rights: US and Canada
02Dec19 15:00 RNS Total Voting Rights
02Dec19 15:00 RNS Block listing Interim Review
29Nov19 07:00 RNS Imfinzi granted FDA Priority Review for SCLC
  • Frequency of research reports

     

  • Research reports on

    AstraZeneca

  • Providers covering

    AstraZeneca